Commentary: Russia reforms obligatory medical insurance, but will this help patients?
This article was originally published in Scrip
Insurance companies and public organisations are concerned about the contents of the bill just as they were concerned about the quality of two other recent bills, on the circulation of medicines (scripnews.com, 19 March 2010) and changing the legal status of state and municipal institutions, including hospitals (scripnews.com, 28 April 2010).
You may also be interested in...
Poland's president, Bronislaw Komorowski, has signed a reimbursement bill into the law which will come into force on 1 January.
In the past two years, most multinational pharmaceutical companies announced plans to create production facilities in Russia. They had been ignoring such an opportunity for years, and there were reasons for that. They included risks to investments, administrative barriers, unclear regulations assuming various interpretations and corruption.
Russia's president Dmitriy Medvedev has requested that his government start talks with the US and the EU on the mutual recognition of clinical trial results (including paediatric trials) and prepare proposals for corresponding amendments of existing regulations.